Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 212

Results For "Pharma"

3731 News Found

Strides receives USFDA approval for Icosapent Ethyl Capsules
Drug Approval | September 25, 2023

Strides receives USFDA approval for Icosapent Ethyl Capsules

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)


Lupin acquires five brands from Menarini
News | September 23, 2023

Lupin acquires five brands from Menarini

Lupin has been exclusively marketing these brands in the Indian market since July 2021


Emmes appoints Peter Ronco as CEO
People | September 23, 2023

Emmes appoints Peter Ronco as CEO

Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri


Natural Biogenex performs inauguration at Tumkur unit
News | September 22, 2023

Natural Biogenex performs inauguration at Tumkur unit

This production block consists of chemical synthesis reactions and clean rooms areas to produce final API


USFDA conducts inspection at InvaGen manufacturing facility in Central Islip, NY, USA
Drug Approval | September 21, 2023

USFDA conducts inspection at InvaGen manufacturing facility in Central Islip, NY, USA

InvaGen has received 5 inspectional observations in Form 483


Venus Remedies gets marketing approval for gemcitabine and docetaxel in Serbia
News | September 21, 2023

Venus Remedies gets marketing approval for gemcitabine and docetaxel in Serbia

With this, the company has secured 511 marketing approvals for its oncology products across 66 countries


Parexel appoints Gwyn Bebb to lead oncology clinical development
People | September 21, 2023

Parexel appoints Gwyn Bebb to lead oncology clinical development

Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need


Cenexi appoints Jim McPherson as CEO
People | September 20, 2023

Cenexi appoints Jim McPherson as CEO

Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK


Briefs: Caplin Steriles, Zydus  and APL Healthcare
Drug Approval | September 20, 2023

Briefs: Caplin Steriles, Zydus and APL Healthcare

Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients


CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData
Diagnostic Center | September 19, 2023

CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData

CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology